Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMPICILLIN Cause Condition aggravated? 108 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Condition aggravated have been filed in association with AMPICILLIN (Ampicillin and Sulbactam). This represents 3.0% of all adverse event reports for AMPICILLIN.

108
Reports of Condition aggravated with AMPICILLIN
3.0%
of all AMPICILLIN reports
25
Deaths
55
Hospitalizations

How Dangerous Is Condition aggravated From AMPICILLIN?

Of the 108 reports, 25 (23.1%) resulted in death, 55 (50.9%) required hospitalization, and 16 (14.8%) were considered life-threatening.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMPICILLIN. However, 108 reports have been filed with the FAERS database.

What Other Side Effects Does AMPICILLIN Cause?

Drug hypersensitivity (566) Drug ineffective (540) Maternal exposure during pregnancy (485) Foetal exposure during pregnancy (474) Premature baby (404) Premature delivery (330) Product use in unapproved indication (224) Off label use (204) Rash (150) Low birth weight baby (127)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which AMPICILLIN Alternatives Have Lower Condition aggravated Risk?

AMPICILLIN vs AMPICILLIN\SULBACTAM AMPICILLIN vs AMPRENAVIR AMPICILLIN vs AMPYRA AMPICILLIN vs AMRUBICIN AMPICILLIN vs AMSACRINE

Related Pages

AMPICILLIN Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated AMPICILLIN Demographics